Incannex Healthcare (IXHL) Gains from Investment Securities (2024 - 2026)
Incannex Healthcare (IXHL) posted Gains from Investment Securities of -$380000.0 for Q1 2026, down 101.61% sequentially from $23.6 million in Q2 2025, and up 79.17% YoY from -$212093.0 in Q1 2025.
Incannex Healthcare (IXHL) Gains from Investment Securities (2024 - 2026) Analysis & Trends
Incannex Healthcare has reported Gains from Investment Securities for 3 years, with the latest figure at -$380000.0 in Q1 2026.
- Quarterly Gains from Investment Securities rose 79.17% year-over-year to -$380000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $21.5 million (changed N/A YoY) and the FY2025 annual result came in at $21.9 million, changed N/A from the prior year.
- Gains from Investment Securities eased to -$380000.0 in Q1 2026 per IXHL's latest filing, from $23.6 million in the prior quarter.
- Over five years, Gains from Investment Securities peaked at $23.6 million in Q2 2025 and troughed at -$1.8 million in Q1 2025.
- A 3-year average of $5.4 million and a median of -$138500.0 in 2024 frame the typical range for Gains from Investment Securities.
- The widest YoY moves for Gains from Investment Securities: up 79.17% in 2026, down 79.17% in 2026.
- Over 3 years, Gains from Investment Securities stood at $103000.0 in 2024, then soared by 22857.28% to $23.6 million in 2025, then slumped by 101.61% to -$380000.0 in 2026.
- According to Business Quant data, Gains from Investment Securities over the past three periods registered -$380000.0, $23.6 million, and -$1.8 million for Q1 2026, Q2 2025, and Q1 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Incannex Healthcare | 44.39 Mn | 44.39 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -380,000.00 |
| Mar 31, 2026 | -380,000.00 |
| Jun 30, 2025 | 23.65 Mn |
| Jun 30, 2025 | 23.65 Mn |
| Mar 31, 2025 | -1.82 Mn |
| Mar 31, 2025 | -1.82 Mn |
| Dec 31, 2024 | 103,000.00 |
| Dec 31, 2024 | 103,000.00 |